Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: silver nanoparticles

November 27, 2025 Analysis / Non-pharma applications

Paper strips with β-Cyclodextrin-functionalized silver nanoparticles as a visual probe for selective tetrahydrocannabinol detection

This study presents a novel, facile approach for the colorimetric detection of tetrahydrocannabinol (THC) using β-cyclodextrin functionalized silver nanoparticles (β-CD-AgNPs),

Continue reading

June 27, 2023 CD derivatives / Drug delivery

Synthesis of cationic β-cyclodextrin functionalized silver nanoparticles and their drug-loading applications

Silver nanoparticles have attracted great attention owing to their distinct physicochemical properties, which inspire the development of their synthesis methodology

Continue reading

January 12, 2023 Drug delivery / Pharma applications

Sustainable γ-cyclodextrin frameworks containing ultra-fine silver nanoparticles with enhanced antimicrobial efficacy

Cyclodextrin metal-organic frameworks (CD-MOF) are a class of biocompatible MOFs with a great potential in drug delivery applications. Original CD-MOF

Continue reading

December 10, 2021 Drug delivery / Pharma applications

Cyclodextrin-based nanoparticles for pharmaceutical applications: a review

Cyclodextrin-conjugated nanoparticles combine the advantages of cyclodextrins and nanoparticles: enhanced water solubility and drug loading, targeted drug delivery with minimum

Continue reading

Recent Posts

  • Call for Chapters: Cyclodextrins in Nutraceuticals 
  • Comparison of the siRNA and mRNA Carrying Capacity of Quaternary Ammonium β-Cyclodextrin Polymer and Polyethylenimine
  • Call for Chapters: Cyclodextrins in Phytomedicine
  • Poly-CD-PEG-camptothecin Combined with Olaparib  in People With Relapsed/​Refractory Small Cell Lung Cancer (Clinical trial)
  • Alkali Metal Adduct Formation in Cyclic Ion Mobility-Mass Spectrometry of O-Methylated Cyclodextrin Isomers

Tags

alpha-CD Alzheimer disease atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (27)
  • Analysis (71)
  • CD as API (348)
  • CD derivatives (416)
  • Cosmetics and toilettry (52)
  • Diagnosis (13)
  • Drug delivery (798)
  • E-ducation (63)
  • Environmental (137)
  • Events (234)
  • Food (225)
  • Gene delivery (22)
  • Household products (5)
  • Household products (1)
  • In Hungarian (4)
  • Life sciences (43)
  • Non-pharma applications (403)
  • Other industrial use (108)
  • Pharma applications (1,191)
  • Supramolecular systems (42)
  • Uncategorized (152)

Top Posts

  • Call for Chapters: Cyclodextrins in Phytomedicine
  • Poly-CD-PEG-camptothecin Combined with Olaparib  in People With Relapsed/​Refractory Small Cell Lung Cancer (Clinical trial)
  • Comparison of the siRNA and mRNA Carrying Capacity of Quaternary Ammonium β-Cyclodextrin Polymer and Polyethylenimine
  • Call for Chapters: Cyclodextrins in Nutraceuticals 
  • New FDA approved medicinal product containing Betadex sulfobutylether sodium: VYKOURA
  • GRAS status of CD derivatives
  • Cyclarity Unveils First-Ever Clinical Data Demonstrating Excretion of Oxidized Cholesterol, at American Heart Association Vascular Discovery Scientific Sessions
  • Citric acid cross-linked β-cyclodextrins: A review of preparation and environmental/biomedical application
  • A Cyclodextrin Surprise in a Japanese Supplement
  • HPBCD in pet care: shampoo and deodorising spray for dogs

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,474 other subscribers

Loading Comments...